Edition:
United Kingdom

Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

5.37USD
17 Jul 2019
Change (% chg)

$-0.54 (-9.14%)
Prev Close
$5.91
Open
$5.90
Day's High
$5.95
Day's Low
$5.32
Volume
158,635
Avg. Vol
225,722
52-wk High
$26.24
52-wk Low
$4.17

Summary

Name Age Since Current Position

Brian Griffin

60 2018 Chairman of the Board, Chief Executive Officer

Philip Hagerman

66 2018 Chairman Emeritus

Daniel Davison

59 2019 Chief Financial Officer, Treasurer

Dave Loschinskey

2019 Chief Operating Officer

Benjamin Wolin

44 2018 Lead Independent Director

Regina Benjamin

62 2017 Independent Director

David Dreyer

62 2014 Independent Director

Kenneth Klepper

65 2014 Independent Director

Shawn Tomasello

60 2015 Independent Director

Terri Powers

2018 Vice President, Investor Relations

Biographies

Name Description

Brian Griffin

Mr. Brian T. Griffin is Chairman of the Board, Chief Executive Officer of the Company. He has more than 30 years of experience as a results-driven healthcare executive. Mr. Griffin's dynamic skillset is rooted in deep expertise in pharmacy benefit management, specialty pharmacy, and health plan leadership. he served since March 2018 as executive vice president and CEO for IngenioRx, the pharmacy benefit manager he led the building and launch of for Anthem. For the previous three years, Mr. Griffin led Anthem's commercial and specialty business division. He joined the company in 2013 as president and CEO of its second-largest affiliated health plan, Empire BlueCross BlueShield. Before his time with Anthem, he spent 25 years at Medco Health Solutions, which was acquired by Express Scripts in 2012. In more than a decade as president of Medco's health plan division, Mr. Griffin managed relationships with national and regional health plans, BlueCross BlueShield plans, commercial insurance carriers, consumer-driven plans, and third-party administrators. Mr. Griffin has extensive managerial, operating, regulatory, compliance, financial and accounting experience, and expertise, including significant experience in driving growth through acquisitions and organically, from his various executive management positions. In particular, his services as an executive for over 35 years in the healthcare industry, including more than five years as a leading executive at one of the largest health benefits companies in the United States and 10 years as a leading executive for a provider of specialty pharmaceutical services, provides him critical industry insight and relationships and related operations, strategic, marketing, acquisition, and senior leadership expertise

Philip Hagerman

Mr. Philip R. Hagerman is Chairman Emeritus of Diplomat Pharmacy, Inc. previously served as Diplomat's Chairman of the Board of Directors and Chief Executive Officer. He has been a director since 1991. Mr. Hagerman co-founded Diplomat with his father in 1975. Mr. Hagerman is also the founder, co-owner and chief executive officer of Skypoint Ventures, an investment entity he founded in 2014. Mr. Hagerman led Diplomat as its principal executive officer and Chairman of the Board of Directors, and his service as a director has continued for approximately 27 years. He has a unique perspective and understanding of our business, culture and history, having led Diplomat through many economic cycles and operational initiatives. His many years of day-to-day leadership of Diplomat gives him critical insights into our operations, strategy and competition. Throughout his career at Diplomat, he demonstrated strong entrepreneurial skills, as well as regulatory, marketing, strategic, and operational expertise. Mr. Hagerman also possesses in-depth knowledge of, and key relationships in, the specialty pharmacy industry on a national basis.

Daniel Davison

Mr. Daniel Paul Davison is appointed as Chief Financial Officer, Treasurer of the Company, effective April 8, 2019. Mr. Davison has over 25 years of experience in the pharmacy benefit management ("PBM") and specialty pharmacy industries. Prior to joining the Company, Mr. Davison served as Senior Vice President, PBM Finance of CVS Health (NYSE: CVS), one of the largest health care companies in the United States, from January 2014 to December 2018, where he managed the finance, planning and accounting functions for the CVS/Caremark and CVS/Specialty groups within the CVS Pharmacy Services Segment. Prior to this position, Mr. Davison served from 1994 to 2012 in a number of leadership roles at Medco Health Solutions, Inc., a provider of PBM and specialty pharmaceutical services (which was acquired by Express Scripts Holding Company, Inc. in 2012), including as Senior Vice President of Financial and Strategic Planning from March 2008 to April 2012 and Chief Financial Officer of the Health Plan division from April 2004 to March 2008.

Dave Loschinskey

Benjamin Wolin

Mr. Benjamin Wolin has been appointed Lead Independent Director of Diplomat Pharmacy, Previously, Mr. Wolin served as independent Lead Director from February 2017 to January 2018 and as Chairman of the Board from January 2018 until June 2018. Mr. Wolin was the Co-founder, Chief Executive Officer, and a member of the board of directors of Everyday Health, Inc., a leading provider of digital health and wellness solutions, from January 2002 until its sale to a subsidiary of j2 Global, Inc. in December 2016. From September 1999 until December 2001, Mr. Wolin served as Vice President of Production and Technology for Beliefnet, Inc., an online provider of religious and spiritual information. Previously, Mr. Wolin served as Web Producer for Tribune Interactive, Inc., a multimedia corporation, and held several consulting positions with interactive companies. In March 2018, Mr. Wolin was appointed to the board of Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company, where he serves as Chairman of the Board and as a member of the Compensation Committee. In February 2019, Mr. Wolin was appointed to the board of Covetrus, Inc. (Nasdaq: CVET), a global, technology-enabled animal health business, where he serves as a member of the Compensation Committee and a member of the Strategy Committee.

Regina Benjamin

Dr. Regina M. Benjamin, M.D., MBA serves as Independent Director of the Company. Dr. Benjamin is the Former United States Surgeon General and a practicing family physician. In July 2009, Dr. Benjamin was appointed as the 18th United States Surgeon General and served a four-year term. During such period, Dr. Benjamin served as the Chair of the National Prevention, Health Promotion, and Public Health Council, which consists of 17 cabinet-level Federal agencies that released the first ever National Prevention Strategy, a roadmap for health. In addition, since September 2013, Dr. Benjamin has served as the NOLA.com/Times Picayune Endowed Chair in Public Health Sciences at Xavier University of Louisiana. Dr. Benjamin is the founder and CEO of BayouClinic, Inc., a Federally Qualified Health Center Look-Alike clinic in Alabama which Dr. Benjamin founded in 1990. From December 2013 through July 2015, Dr. Benjamin served on the board of directors of Alere Inc., a healthcare diagnostics company, where she served on the nominating and corporate governance committee. Dr. Benjamin also currently serves on boards of directors of Kaiser Foundation Hospitals and Health Plan since 2015, as well as Ascension healthcare system and the national board of the March of Dimes. In addition, Dr. Benjamin joined the board of Computer Programs and Systems, Inc. (NASDAQ: CPSI) in November 2017 and she currently serves on the Nominating and Corporate Governance Committee.

David Dreyer

Mr. David C. Dreyer, CPA, is an Independent Director of Diplomat Pharmacy, Inc. Mr. Dreyer currently serves as Chief Financial Officer for Prolacta Bioscience, Inc., a privately held bioscience and high growth biopharmaceutical company focused on treating premature babies in Neonatal Intensive Care Units. Mr. Dreyer started at Prolacta in February 2017. Previously, Mr. Dreyer served as Chief Financial Officer at BIOLASE, Inc. (Nasdaq:BIOL), a medical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine as well as other digital equipment, from March 2015 to January 2017. From October 2010 to March 2015, Mr. Dreyer served as Chief Financial Officer, Chief Operating Officer and Secretary of Patient Safety Technologies, which develops, markets and sells healthcare products relating to surgical safety, and is a former public reporting company and a subsidiary of Stryker Corporation (NYSE: SYK) since March 2014. Previously, Mr. Dreyer was Chief Financial Officer of Alphastaff Group, Inc., a human resource outsourcing company, from August 2009 to September 2010. From September 2004 to August 2009, Mr. Dreyer served as Chief Financial Officer and Chief Accounting Officer of AMN Healthcare Services, Inc., which provided healthcare staffing for physicians, travel nurses, and allied travel. From 1997 through 2004, Mr. Dreyer served as Chief Financial Officer and Chief Accounting Officer of Sicor, Inc., a manufacturer of complex pharmaceuticals with operations in the United States and internationally, which was acquired by Teva Pharmaceutical Limited in January 2004.

Kenneth Klepper

Mr. Kenneth O. Klepper is an Independent Director of Diplomat Pharmacy, Inc. He currently serves as Co-Founder, Chairman, and Chief Executive Officer of ReactiveCore, Inc., an enterprise AIOS (Artificial Intelligence Operating System) technology start-up company, an entity he co-founded in March 2015. He previously served as President and Chief Operating Officer of Medco Health Solutions, Inc., a supplier of pharmacy benefit management, mail order, and specialty pharmacy services, from March 2006 until the April 2012 acquisition of Medco by Express Scripts, Inc. He joined Medco in June 2003 and served as Executive Vice President, Chief Operating Officer from June 2003 through March 2006. Previously, Mr. Klepper was employed by WellChoice, Inc., a health insurance company and parent of Empire Blue Cross Blue Shield of New York, where he held the positions of Senior Vice President, Process Champion from March 1995 to August 1999 and Senior Vice President for Systems, Technology and Infrastructure from August 1999 to April 2003. From 1991 to 1995, Mr. Klepper served in management roles at CIGNA Health Care (NYSE: CI). Mr. Klepper is a former member of the Defense Business Board and the Chief of Naval Operations Executive Panel, where he served five CNOs. He also serves on the Board of Directors at the United States Naval Institute.

Shawn Tomasello

Ms. Shawn Cline Tomasello is an Independent Director of Diplomat Pharmacy, Inc. Since December 2015, Ms. Tomasello served as the Chief Commercial Officer of Kite Pharma, Inc., a company engaged in the development of cancer immunotherapy products, which was acquired by Gilead Sciences, Inc. in August 2017, from December 2015 to July 2018. Prior to joining Kite Pharma, Ms. Tomasello served as the Chief Commercial Officer of Pharmacyclics Inc., a pharmaceutical manufacturer acquired by Abbvie, Inc. in 2015, a position she held from August 2014 to July 2015. From April 2005 to August 2014, Ms. Tomasello was employed at Celgene Corporation (Nasdaq: CELG), initially as the Vice President, Sales and Training, and then as President of the Americas, Hematology and Oncology, where she was responsible for all aspects of the commercial organization encompassing multiple brands spanning 11 indications. Prior to joining Celgene Corporation, Ms. Tomasello was with Genentech, Inc. from 1989 through 2005. Her last position at Genentech was National Director, Hematology Franchise (Rituxan®) from early 2003 to April 2005. Ms. Tomasello has served on the board of Urogen Pharma, Ltd. (Nasdaq: URGN), a clinical-stage biopharmaceutical company developing advanced non-surgical treatments in the field of urology, with a focus on uro-oncology, since July 2018. Ms. Tomasello has also served on the board of Mesoblast Limited (Nasdaq: MESO), a clinical development cell therapy company, since July 2018..

Terri Powers

Basic Compensation

Name Fiscal Year Total

Brian Griffin

9,771,880

Philip Hagerman

459,636

Daniel Davison

--

Dave Loschinskey

--

Benjamin Wolin

258,158

Regina Benjamin

208,774

David Dreyer

231,180

Kenneth Klepper

216,986

Shawn Tomasello

206,771

Terri Powers

--
As Of  31 Dec 2018